临床外科杂志 ›› 2025, Vol. 33 ›› Issue (11): 1170-1174.doi: 10.3969/j.issn.1005-6483.20240898

• 论著 • 上一篇    下一篇

甲状腺乳头状癌组织中HMGA2和ADAMTS8蛋白水平与临床病理参数及预后的关系

  

  1. 223800  江苏宿迁,宿迁市第一人民医院甲乳外科
  • 收稿日期:2024-06-11 接受日期:2024-06-11 出版日期:2025-11-20 发布日期:2025-11-20
  • 通讯作者: 朱小朝,Email:zhuxc05206@126.com

Relationship between HMGA2 and ADAMTS8 protein levels in papillary thyroid carcinoma tissue with clinical pathological parameters and prognosis

  1. Department of Breast Surgery,Suqian First People's Hospital,Suqian 223800,China
  • Received:2024-06-11 Accepted:2024-06-11 Online:2025-11-20 Published:2025-11-20
  • Supported by:
    2021年度徐州医科大学附属医院发展基金项目(XYFZ2021008)

摘要: 目的 探讨甲状腺乳头状癌(PTC)组织中高迁移率族蛋白A2(HMGA2)和具有血小板反应蛋白基序8的解整合素和金属蛋白酶(ADAMTS8)蛋白水平与临床病理参数及预后的关系。方法 收集2018年12月~2020年12月于本院行甲状腺切除术的128例PTC病人的癌组织及癌旁组织,收集其临床病理资料。采用免疫组织化学法检测组织中HMGA2和ADAMTS8蛋白表达水平,并分析其与临床病理参数的关系;采用KaplanMeier曲线分析HMGA2和ADAMTS8表达与PTC病人预后的关系;多因素Cox回归分析HMGA2和ADAMTS8表达对PTC病人预后的影响。结果 PTC组织和癌旁组织中HMGA2蛋白阳性表达率分别为64.84%、32.03%,ADAMTS8蛋白阳性表达率分别为61.72%、34.38%,两组比较差异有统计学意义(P<0.001);PTC组织中HMGA2和ADAMTS8蛋白表达水平与脉管侵犯、TNM分期、淋巴结转移、分化程度有关(P<0.05);HMGA2和ADAMTS8阳性表达病人3年生存率低于阴性表达病人,差异有统计学意义(χ2=4.807、4.236,P<0.05);HMGA2(HR=1.752,95%CI=1.129~2.718)和ADAMTS8(HR=1.497,95%CI=1.113~2.013)阳性表达是PTC病人死亡的危险因素(P<0.05)。结论 PTC组织中HMGA2和ADAMTS8蛋白阳性表达率较高,二者表达水平与临床病理参数及预后有关。

关键词: 甲状腺乳头状癌, 高迁移率族蛋白2, ADAMTS8, 临床病理参数, 预后

Abstract: Objective  To investigate the relationship between the levels of high mobility group protein A2(HMGA2) and a disintegrin and metalloproteinase with thrombospondin motifs 8(ADAMTS8) in papillary thyroid carcinoma(PTC) tissue with clinical pathological parameters and prognosis.Methods Cancer and adjacent tissues of 128 PTC patients who underwent thyroidectomy in our hospital from December 2018 to December 2020 were collected,and clinical and pathological characteristics of the patients were collected.Immunohistochemical staining was applied to detect the expression levels of HMGA2 and ADAMTS8 proteins in tissues,and their relationship with clinical pathological parameters was analyzed.Kaplan-Meier curve was applied to analyze the relationship between HMGA2 and ADAMTS8 expression and the prognosis of PTC patients.Multivariate Cox regression was applied to analyze the impacts of HMGA2 and ADAMTS8 expression on the prognosis of PTC patients.Results The positive expression rates of HMGA2 protein in PTC tissues and adjacent tissues were 64.84% and 32.03%,respectively,and the positive expression rates of ADAMTS8 procoprotein were 61.72% and 34.38%,respectively.There was a statistically significant difference between the two groups (P < 0.001).The expression levels of HMGA2 and ADAMTS8 proteins in PTC tissue were related to vascular invasion,TNM staging,lymph node metastasis,and differentiation degree(P<0.05).The 3-year survival rate of HMGA2 and ADAMTS8 positive expression patients was lower than that of negative expression patients(χ2=4.807,4.236,P<0.05).Positive expression of HMGA2(HR=1.752,95%CI=1.129~2.718) and positive expression of ADAMTS8(HR=1.497,95%CI=1.113~2.013) were risk factors for mortality in PTC patients(P<0.05).Conclusion The positive expression rates of HMGA2 and ADAMTS8 proteins are relatively high in PTC tissues,and their expression levels are related to clinical pathological parameters and prognosis,which has certain clinical value.

Key words: thyroid papillary carcinoma, high mobility group protein A2, a disintegrin and metalloproteinase with thrombospondin motifs 8, clinical pathological parameters, prognosis

[1] 杜宁彬 王居正 郭玲 胡艳正. 长链非编码RNA XIST和微小RNA-186-5p在非小细胞肺癌组织中的表达及其与病理特征的相关性[J]. 临床外科杂志, 2025, 33(9): 953-957.
[2] 杨谦 张军 马玉泉 李志国 毛诏旭. 肺腺癌组织lncRNA MALAT1、miR-181a-5p表达与JAK2/STAT3信号通路、临床病理特征及预后的关系[J]. 临床外科杂志, 2025, 33(9): 958-963.
[3] 方丽 田云霄 高庆利 牛广旭. 细胞周期蛋白B2、细胞周期蛋白E表达与肝癌病人临床病理特征及5年生存率的关系分析[J]. 临床外科杂志, 2025, 33(9): 981-984.
[4] 孙磊 杨玉亭 李朝辉. 胫骨平台伴髁间棘骨折病人术后关节功能恢复的影响因素及其预测效能研究[J]. 临床外科杂志, 2025, 33(9): 992-996.
[5] 黄志刚 张兴伟 张宇 邹青旭. N-乙酰转移酶10、丝氨酸羟甲基转移酶 2、YTHN6-甲基腺苷RNA结合蛋白1在肺癌组织中的表达及与临床病理特征、预后的相关性[J]. 临床外科杂志, 2025, 33(8): 827-831.
[6] 汪俊 吕瑕智 陶玉 胡传朋. 血清微小核糖核酸-335-5p、内皮细胞特异性分子-1对食管癌病人的早期诊断及预后评估价值[J]. 临床外科杂志, 2025, 33(8): 836-840.
[7] 郝博 王霞 张婷. 血清半乳糖凝集素3结合蛋白生长分化因子-15联合对重症急性胰腺炎病人的预后价值[J]. 临床外科杂志, 2025, 33(7): 693-.
[8] 牛磊 霍承瑜 刘宗志. 纤维蛋白原与白蛋白比值、预后营养指数、系统性免疫炎症指数与肺癌胸腔镜肺叶切除术病人预后关系的研究[J]. 临床外科杂志, 2025, 33(7): 708-.
[9] 聂磊 张海艳 沈健 吴东德. 胆道癌靶向免疫治疗研究进展[J]. 临床外科杂志, 2025, 33(7): 775-.
[10] 孙宇 郝立政 胡晓立. 血清G蛋白信号调节因子2、适配器相关蛋白复合物3亚基mu2与早期结直肠癌病人临床病理特征及预后的相关性分析[J]. 临床外科杂志, 2025, 33(6): 623-627.
[11] 颜淼 卢逸 张信华. 晚期胃肠间质瘤手术治疗的价值和相关进展[J]. 临床外科杂志, 2025, 33(6): 661-664.
[12] 贾颖玉 李炳梁 任红霞. 先天性巨结肠早期手术干预的中期预后及发生相关小肠结肠炎风险的评[J]. 临床外科杂志, 2025, 33(5): 474-477.
[13] 陈力 潘登 穆鑫 刘会锋 杨敏 王献良. 腹腔镜Soave术治疗年龄<6个月常见型先天性巨结肠的预后分析[J]. 临床外科杂志, 2025, 33(5): 478-481.
[14] 王刚 拜夏睿 梁姣 南李刚. 颅脑损伤病人胃肠功能障碍的临床危险因素分析[J]. 临床外科杂志, 2025, 33(5): 511-513.
[15] 邓亦奇, 孙永杰, 邹士东, 王乃国, 汪明星. 椎间孔镜下髓核摘除术治疗单节段腰椎间盘突出症病人血清炎性指标与短期预后的相关性[J]. 临床外科杂志, 2025, 33(4): 375-378.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 黄洪锋. 关注公民逝世后器官捐献肾移植受体围手术期感染的预防与处理[J]. 临床外科杂志, 2016, 24(10): 732 .
[2] 林俊. 原发性中枢神经系统恶性肿瘤供者在器官移植中的应用[J]. 临床外科杂志, 2016, 24(10): 737 .
[3] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[4] 石宇;刘学刚 . 冠状动脉旁路移植术后短期内应用强化他汀对患者出血风险的研究[J]. 临床外科杂志, 2016, 24(10): 750 .
[5] 陈忠;王耀东;田毅峰;等. 肝胆管结石病规范化治疗的临床分析[J]. 临床外科杂志, 2016, 24(10): 753 .
[6] 江帆;孙权;吴国俊;等. 不同引流方式对恶性梗阻性黄疸患者细胞免疫的影响[J]. 临床外科杂志, 2016, 24(10): 760 .
[7] 阿布力克木·毛拉尤甫;郑秉礼. 胰腺实性假乳头状瘤45例手术治疗分析[J]. 临床外科杂志, 2016, 24(10): 764 .
[8] 胡志伟;汪忠镐;张玉;等. 腹腔镜Toupet胃底折叠术治疗干燥综合征合并严重胃食管反流病两例[J]. 临床外科杂志, 2016, 24(10): 766 .
[9] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[10] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .